June 2014 FDA Recall Drug by Mylan Pharmaceuticals Inc.
D-1539-2014 - Failed Impurities/Degradation Specifications; Out of specification for lactol and total impurities.
This Class III drug recall was voluntarily initiated by Mylan Pharmaceuticals Inc. on June 20, 2014 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications; out of specification for lactol and total impurities.. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1539-2014
Failed Impurities/Degradation Specifications; Out of specification for lactol and total impurities.
06-20-2014
08-27-2014
9225 Bottles
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Mylan Pharmaceuticals Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
U.S. Nationwide
10-09-2015
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Tolterodine Tartrate Tablets, 1 mg, 60 Tablet Bottles, Rx only. Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-5445-91.
Batch or Lot Expiration Information
Lot# 2004069, Expiry: 09/2014
Lot# : 2004070, Expiry: 09/2014.